Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38550 |
Onilcamotide
|
||
Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities. |